CSIMarket



Merck and Co Inc   (MRK)
Other Ticker:  
 
 

MRK's Operating Income Growth by Quarter and Year

Merck And Co Inc 's Operating Income results by quarter and year




MRK Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 3,094.00 -2,249.00 2,567.00
III Quarter September - 4,816.00 3,116.00 2,382.00
II Quarter June - 1,614.00 3,129.00 3,399.00
I Quarter March 5,569.00 3,014.00 3,909.00 3,255.00
FY   5,569.00 12,538.00 7,905.00 11,603.00



MRK Operating Income first quarter 2022 Y/Y Growth Comment
Merck and Co Inc achieved in the first quarter 2022, above Company average Operating Income rise of 84.77% year on year, to $ 5,569.00 millions.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Operating Income growth. While Merck And Co Inc ' s Operating Income jump of 84.77% ranks overall at the positon no. 236 in the first quarter 2022.

Explain Operating Income growth


MRK Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -5.42 %
III Quarter September - 54.56 % 30.81 % -4.45 %
II Quarter June - -48.42 % -7.94 % 66.78 %
I Quarter March 84.77 % -22.9 % 20.09 % 208.82 %
FY   - 58.61 % -31.87 % 39.81 %

Financial Statements
Merck And Co Inc 's first quarter 2022 Operating Income $ 5,569.00 millions MRK's Income Statement
Merck And Co Inc 's first quarter 2021 Operating Income $ 3,014.00 millions Quarterly MRK's Income Statement
New: More MRK's historic Operating Income Growth >>


MRK Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -35.76 % - 7.77 %
III Quarter September - 198.39 % -0.42 % -29.92 %
II Quarter June - -46.45 % -19.95 % 4.42 %
I Quarter March 79.99 % - 52.28 % 19.93 %
FY (Year on Year)   - 58.61 % -31.87 % 39.81 %




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #13
Overall #236

Operating Income Y/Y Growth Statistics
High Average Low
1067.22 % 17.92 % -89.25 %
(Dec. 30, 2008)   (Dec. 30, 2007)
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #6
Healthcare Sector #13
Overall #236
Operating Income Y/Y Growth Statistics
High Average Low
1067.22 % 17.92 % -89.25 %
(Dec. 30, 2008)   (Dec. 30, 2007)

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Merck And Co Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
1532.46 % 37.74 % -95.43 %
(Dec 31 2017)  


MRK's I. Quarter Q/Q Operating Income Comment
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 79.99%, to $ 5,569.00 millions, from $3,094.00 millions in the forth quarter.
Merck And Co Inc is impressively improving, not only reporting above regular increase, but also accelerating speed.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 177.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #13
Overall #177
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #4
Healthcare Sector #13
Overall #177
Operating Income Q/Q Growth Statistics
High Average Low
1532.46 % 37.74 % -95.43 %
(Dec 31 2017)  


MRK's I. Quarter Q/Q Operating Income Comment
Merck and Co Inc achieved in the I. Quarter 2022 above company average sequential Operating Income jump of 79.99%, to $ 5,569.00 millions, from $3,094.00 millions in the forth quarter.
Major Pharmaceutical Preparations company is undergoing a remarkable growth, not only claiming higher then average increase, and also improving pace.

Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Merck And Co Inc 's Operating Income growth quarter on quarter, overall rank is 177.


Merck And Co Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ 15,093.00 $ 12,538.00 $ 7,195.00 $ 5,495.00 $ 7,010.00
Y / Y Operating Income Growth (TTM) 115.31 % 58.61 % -43.44 % -54.16 % -42.81 %
Year on Year Operating Income Growth Overall Ranking # 253 # 479 # 1898 # 1985 # 1482
Seqeuential Operating Income Change (TTM) 20.38 % 74.26 % 30.94 % -21.61 % -11.32 %
Seq. Operating Income Growth (TTM) Overall Ranking # 236 # 208 # 376 # 2000 # 387




Cumulative Operating Income growth Comment
Merck And Co Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 115.31% year on year, to $ 15,093 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Operating Income growth was higher than company's average 59.76% and higher than 58.61% growth in Dec 31 2021.
But sequential growth rate was slower at 20.38 % from $12538 millions recorded in twelve months ending a quarter Dec 31 2021 Alexander P. Robinson added on.
Yet this was evidence of strength, as the average sequential advancement stands at 17.92%.
The progress is even stronger sequentially exhibited at 20.38 % increase from $12538 millions in the period from Dec 31 2021 to Mar 31 2021.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 253, from total ranking in previous quarter at 479.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1067.22 %
17.92 %
-89.25 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 15
Overall # 253

Operating Income TTM Y/Y Growth Statistics
High Average Low
1129.36 %
59.76 %
-89.44 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 13
S&P 500 # 236
Cumulative Operating Income growth Comment
Merck And Co Inc saw improvement in Operating Income growth trend, posting cumulative 12 months Operating Income growth of 115.31% year on year, to $ 15,093 millions if the fiscal year would have ended in Mar 31 2022.
Merck And Co Inc 's trailing twelve months Operating Income growth was higher than company's average 59.76% and higher than 58.61% growth in Dec 31 2021.
But from twelve months ended Dec 31 2021 increase was beneth at 20.38 % from $12538 millions achieved in twelve months ending a quarter before.
In spite of, this was evidence of strength, while the usual Q/Q TTM gain lays at 17.92%.
The growth is even higher sequentially showed at 20.38 % increase from $12538 millions in the period from Dec 31 2021 to Mar 31 2021.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 253, from total ranking in previous quarter at 479.

Operating Income TTM Q/Q Growth Statistics
High Average Low
1067.22 %
17.92 %
-89.25 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 6
Healthcare Sector # 15
Overall # 253

Operating Income TTM Y/Y Growth Statistics
High Average Low
1129.36 %
59.76 %
-89.44 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 13
S&P 500 # 236




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
MRK's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for MRK's Competitors
Operating Income Growth for Merck And Co Inc 's Suppliers
Operating Income Growth for MRK's Customers

You may also want to know
MRK's Annual Growth Rates MRK's Profitability Ratios MRK's Asset Turnover Ratio MRK's Dividend Growth
MRK's Roe MRK's Valuation Ratios MRK's Financial Strength Ratios MRK's Dividend Payout Ratio
MRK's Roa MRK's Inventory Turnover Ratio MRK's Growth Rates MRK's Dividend Comparisons



Companies with similar Operating Income jump for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Insulet Corporation132.52%$ 132.515 millions
Pacific Health Care Organization Inc.117.35%$ 117.350 millions
Amphastar Pharmaceuticals Inc 109.72%$ 109.722 millions
Eli Lilly And Company108.11%$ 108.110 millions
Ethema Health Corporation 93.26%$ 93.259 millions
Harmony Biosciences Holdings inc 89.61%$ 89.610 millions
Merck and Co Inc 84.77%$ 84.771 millions
Maravai Lifesciences Holdings Inc 81.05%$ 81.050 millions
Option Care Health Inc 79.57%$ 79.573 millions
Catalyst Pharmaceuticals Inc 77.19%$ 77.186 millions
Iradimed Corp73.04%$ 73.040 millions
Viemed Healthcare Inc 68.77%$ 68.769 millions
Repligen Corp64.91%$ 64.912 millions
Alr Technologies Inc 58.99%$ 58.990 millions
Surgery Partners Inc 56.14%$ 56.143 millions
Assertio Holdings inc 53.98%$ 53.976 millions
Integra Lifesciences Holdings Corp50.30%$ 50.303 millions
Becton Dickinson And Company50.23%$ 50.230 millions
Mednax Inc 49.82%$ 49.816 millions
Iqvia Holdings Inc 44.74%$ 44.737 millions
The Pennant Group Inc 44.20%$ 44.203 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TFLG's Profile

Stock Price

TFLG's Financials

Business Description

Fundamentals

Charts & Quotes

TFLG's News

Suppliers

TFLG's Competitors

Customers & Markets

Economic Indicators

TFLG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071